Denka buys pharming pioneer Icon Genetics
The two-phase sale of Icon Genetics was completed on August 21. Icon Genetics previous owner, German plant biotechnology company NOMAD Bioscience GmbH, already sold 51% of Icon's shares to Denka in August 2015. Now, the Japanese company has acquired the remaining 49% of shares, resulting in Icon Genetics becoming a wholly owned subsidiary of Denka. According to a press release, the total acquisition amount to be paid by DENKA is a maximum of €75 million.